Promoter methylation-mediated inactivation of RASSF1A is common, and aberrations in the ubiquitination pathway further disrupt Hippo signaling, thereby promoting tumor development (Del et al., 2010; Rabizadeh et al., 2004). The gene discussed is RASSF1; the disease is neoplasm.